SCHEMBL24192045

SCHEMBL24192045

O=C(O)c1ccc(Br)c2c3c([nH]c12)CCC1(CCC1)C3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.41
CGAS Q8N884 2/20 0.32
ALOX15 P16050 2/20 0.32
MAPK1 P28482 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MEN1 O00255 1/20 0.32
IKBKB O14920 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
MAPK10 P53779 1/20 0.32
KMT2A Q03164 1/20 0.32
ADRA2A P08913 1/20 0.31
CLCN2 P51788 1/20 0.31
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
KDM5A P29375 1/20 0.30
KDM4C Q9H3R0 1/20 0.30
KDM5B Q9UGL1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24191951 0.97 GFER (0.41) GFERCGASALOX15MAPK1HSD17B10
SCHEMBL30159806 0.95 GFER (0.40) GFERCGASALOX15MAPK1HSD17B10
SCHEMBL30160170 0.95 GFER (0.40) GFERCGASALOX15MAPK1HSD17B10
SCHEMBL24192346 0.85 GFER (0.35) GFER
SCHEMBL24192628 0.85 GFER (0.35) GFER
SCHEMBL30159876 0.84 ALOX15 (0.41) CGASALOX15MAPK1HSD17B10MEN1
SCHEMBL30240146 0.83 GFER (0.37) GFERADRA2ACLCN2
SCHEMBL30240148 0.83 GFER (0.37) GFERADRA2ACLCN2
SCHEMBL24191969 0.82 GFER (0.38) GFER
SCHEMBL148202 0.81 GFER (0.57) GFERALOX15MAPK1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220009920-A1 KINASE INHIBITORS GB005, INC. 2022-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220009920-A1 KINASE INHIBITORS BTK, LYN, LCK GFER 3744/4885CGAS 566/4885ALOX15 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.